I am not a medical professional
Patients were assumed to continue basal insulin therapy (plus concomitant metformin with or without an SGLT-2 inhibitor) for the remainder of their lifetimes, with HbA1c continuing to follow the UKPDS 90 progression equation
X-ray crystallography revealed how DPP-4 cleaves a tripeptide substrate (Ile-Pro-Ile), known as Diprotin-A (PDB ID 1nu8
Mechanism: Both stimulate growth hormone release, but the DAC version has a longer half-life, allowing for less frequent dosing
Additionally, catalase concentrations did not show significant changes in the groups treated with DXN, TIR, or their combination (Figure 6)
Dose 4.5 mg = 1.8 ml, exceeds a 1 ml syringe, requires a 2 ml syringe or two injections